UBS Remains a Hold on ALS Ltd. (CPBLF)
According to TipRanks, Reilly is ranked #1893 out of 8229 analysts.
ALS Ltd. has an analyst consensus of Moderate Buy, with a price target consensus of $8.77.
The company has a one-year high of $10.37 and a one-year low of $6.40. Currently, ALS Ltd. has an average volume of 4,086.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
ALS Ltd. engages in the provision of technical services in the areas of testing, measurement and inspection, and supporting. It operates through the following segments: Life Sciences, Industrial, Commodities, and Other. The Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments around the world in making decisions about environmental, food and pharmaceutical, electronics, and animal health testing matters. The Industrial segment focuses in asset care and tribology testing services to the energy, resources and infrastructure sectors. The Commodities segment involves in assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and gives specialist services to the coal industry such as coal sampling, analysis and certification, formation evaluation services, and related analytical testing. The company was founded in 1863 and is headquartered in Brisbane, Australia.